Pfizer

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

By 

Study: Pfizer COVID pill showed no benefit in younger adults

By 

Pfizer COVID shots appear 73% effective in children under 5

By 

42% of people with regular periods reported heavier bleeding after COVID vaccine, study finds  

By 

Pfizer says tweaked COVID-19 shots boost omicron protection

By 

CDC urges Pfizer booster for children ages 5 to 11

By 

COVID shots still work but researchers hunt new improvements

By 

Fourth vaccine may be needed in the fall, Moderna exec claims

By 

FDA expands Pfizer COVID booster, opens extra dose to age 16

By 

Pfizer says COVID booster offers protection against omicron

By 

LPN Yokasta Castro, theGrio.com

US expands COVID boosters to all adults, final hurdle ahead

By 

Pfizer, US ink $5.29B deal for possible COVID-19 treatment

By 

NBA to players, coaches, refs: Booster shots are recommended

By 

Pfizer says COVID-19 pill cut hospital, death risk by 90%

By 

Teen gets COVID-19 vaccine

US gives final clearance to COVID-19 shots for kids 5 to 11

By 

FDA advisers review Pfizer’s COVID-19 vaccine for kids

By 

FDA says Pfizer COVID vaccine looks effective for young kids

By 

Pfizer says COVID-19 vaccine more than 90% effective in kids

By 

Moderna thegrio.com

FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters

By 

Moderna thegrio.com

US expected to authorize mix-and-match COVID booster shots

By